3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase 3
2
Phase NA
1
Phase EARLY_PHASE1
1
Phase 2/3
1
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
5
Neoplasms
3
Recurrence
1
Neuroectodermal Tumors
1
Medulloblastoma
1
Brain Neoplasms
1
Interventions
Temozolomide
6
Radiotherapy
4
Irinotecan
3
lutetium Lu 177 dotatate
2
Nivolumab
2
Carboplatin
2
sonidegib
1
sodium thiosulfate
1
silmitasertib
1
poly ICLC
1
plerixafor
1
olaparib
1
gallium Ga 68 dotatate
1
etoposide phosphate
1
entrectinib
1
dinutuximab
1
bempegaldesleukin
1
adavosertib
1
abemaciclib
1
Vincristine
1
Vascular Endothelial Growth Factor A
1
Vaccines
1
Triiodothyronine
1
TPI-287
1
Surgical Procedures, Operative
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
1
Microarray Analysis
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Medulloblastoma
×
Lomustine
×
Clear all
NCT01614132
2020-03-31
NOA-07
University of Regensburg
Phase 1/2
Completed
33 enrolled